CENTRAL NERVOUS SYSTEM LYMPHOMA
Clinical trials for CENTRAL NERVOUS SYSTEM LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CENTRAL NERVOUS SYSTEM LYMPHOMA trials appear
Sign up with your email to follow new studies for CENTRAL NERVOUS SYSTEM LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Brain lymphoma battle: new trial tests powerful drug cocktails and transplant vs. radiation
Disease control CompletedThis study tested different combinations of high-dose chemotherapy drugs (methotrexate, cytarabine, with or without rituximab and thiotepa) as initial treatment for 227 adults with newly diagnosed primary CNS lymphoma. After chemo, patients who responded well were randomly assign…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
Gene study may predict chemo side effects in lymphoma
Knowledge-focused CompletedThis study looked at how genetic differences affect the body's ability to clear high-dose methotrexate in patients with diffuse large B-cell lymphoma. Researchers analyzed DNA from 20 participants to find specific gene variations linked to slower drug clearance. The goal was to b…
Matched conditions: CENTRAL NERVOUS SYSTEM LYMPHOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC